Back to search

Article

Network Analysis and Molecular Mapping for Alzheimer’s Disease to Reveal the Drug Targets of Arbutin

2023-11-03

Abstract excerpt

<title>Abstract</title> <p>Alzheimer's disease (AD) is a neurodegenerative disease that causes the degradation of brain cells. AD is the most common causative factor of dementia that leads to cognitive decline and loss of independence. Cholinesterase inhibitors and N-methyl-D- aspartate (NMDA) antagonists are currently available drugs to treat AD related symptoms. Several studies have proved that arbutin is found...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
86d502c7-00ef-5a6b-bea5-cc8a69a8c58d
DOI
10.21203/rs.3.rs-3474607/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Network Analysis and Molecular Mapping for Alzheimer’s Disease to Reveal the Drug Targets of ArbutinDOI 10.21203/rs.3.rs-3474607/v1
Key Regulators of Alzheimer’s Disease: Network Biology and In-Silico Analysis with AChE and Glutamate InhibitorsSemantic proximity
The Network Pharmacology Study And Molecular Docking To Investigate The Potential Mechanism of Acoritataninowii Rhizoma Against Alzheimer's DiseaseSemantic proximity
Drug Repurposing for Alzheimer’s Disease Based on Protein‐Protein Interaction NetworkSemantic proximity
Identification of network-based differential gene expression signatures and their transcriptional factors to develop progressive blood biomarkers for Alzheimer’s diseaseSemantic proximity
A network pharmacology approach to identify the mechanisms and molecular targets of curcumin against Alzheimer diseaseSemantic proximity
Identification of candidate biomarkers and signaling pathways associated with Alzheimer's disease using bioinformatics analysis of next generation sequencing data and molecular docking studiesSemantic proximity
Comprehensive Analysis Reveals A Six-Gene Signature and Associated Drugs in Alzheimer DiseaseSemantic proximity
Network Pharmacology Unveils Potential Targets of Madhuca longifolia in Treating Alzheimer’s Disease: An Advanced Strategy in Drug DiscoverySemantic proximity
Prediction of hub genes of Alzheimer’s disease using a protein interaction network and functional enrichment analysisSemantic proximity
Network pharmacology and bioinformatics approach reveals the therapeutic mechanism of action of curcumin in Alzheimer diseaseSemantic proximity
Network-based approach to identify molecular signatures and therapeutic agents in Alzheimer’s diseaseSemantic proximity
Network pharmacology and bioinformatics approach reveals the therapeutic activity and action mechanism of curcumin in Alzheimer diseaseSemantic proximity
Select a neighboring publication to make it the new centre.